Clinical predictors of lung function in patients recovering from mild COVID-19

Abstract Background Few studies have assessed lung function in Hispanic subjects recovering from mild COVID-19. Therefore, we examined the prevalence of impaired pulmonary diffusing capacity for carbon monoxide (DLCO) as defined by values below the lower limit of normal (< LLN, < 5th percentil...

Full description

Bibliographic Details
Main Authors: Arturo Cortes-Telles, Esperanza Figueroa-Hurtado, Diana Lizbeth Ortiz-Farias, Gerald Stanley Zavorsky
Format: Article
Language:English
Published: BMC 2022-07-01
Series:BMC Pulmonary Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12890-022-02086-9
_version_ 1811222898197659648
author Arturo Cortes-Telles
Esperanza Figueroa-Hurtado
Diana Lizbeth Ortiz-Farias
Gerald Stanley Zavorsky
author_facet Arturo Cortes-Telles
Esperanza Figueroa-Hurtado
Diana Lizbeth Ortiz-Farias
Gerald Stanley Zavorsky
author_sort Arturo Cortes-Telles
collection DOAJ
description Abstract Background Few studies have assessed lung function in Hispanic subjects recovering from mild COVID-19. Therefore, we examined the prevalence of impaired pulmonary diffusing capacity for carbon monoxide (DLCO) as defined by values below the lower limit of normal (< LLN, < 5th percentile) or less than 80% of predicted in Hispanics recovering from mild COVID-19. We also examined the prevalence of a restrictive spirometric pattern as defined by the ratio of forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC) being ≥ LLN with the FVC being < LLN. Finally, we evaluated previous studies to find factors correlated to impaired DLCO post-COVID-19. Methods In this observational study, adult patients (n = 146) with mild COVID-19 were recruited from a long-term follow-up COVID-19 clinic in Yucatan, Mexico, between March and August 2021. Spirometry, DLCO, and self-reported signs/symptoms were recorded 34 ± 4 days after diagnosis. Results At post-evaluation, 20% and 30% of patients recovering from COVID-19 were classified as having a restrictive spirometric pattern and impaired DLCO, respectively; 13% had both. The most prevalent reported symptoms were fatigue (73%), a persistent cough (43%), shortness of breath (42%) and a blocked/runny nose (36%). Increased age and a restrictive spirometric pattern increased the probability of having an impaired DLCO while having a blocked nose and excessive sweating decreased the likelihood. The proportion of patients with previous mild COVID-19 and impaired DLCO increased by 13% when the definition of impaired DLCO was < 80% predicted instead of below the LLN. When comparing previous studies, having severe COVID-19 increased the proportion of those with impaired DLCO by 21% compared to those with mild COVID-19. Conclusions One-third of patients with mild COVID-19 have impaired DLCO thirty-four days post-diagnosis. The criteria that define impaired DLCO and the severity of COVID-19 disease affects the proportion of those with impaired DLCO at follow-up. One-fifth of patients have a restrictive spirometric pattern.
first_indexed 2024-04-12T08:22:38Z
format Article
id doaj.art-f820a7104c144461998239e649ddd7be
institution Directory Open Access Journal
issn 1471-2466
language English
last_indexed 2024-04-12T08:22:38Z
publishDate 2022-07-01
publisher BMC
record_format Article
series BMC Pulmonary Medicine
spelling doaj.art-f820a7104c144461998239e649ddd7be2022-12-22T03:40:30ZengBMCBMC Pulmonary Medicine1471-24662022-07-012211810.1186/s12890-022-02086-9Clinical predictors of lung function in patients recovering from mild COVID-19Arturo Cortes-Telles0Esperanza Figueroa-Hurtado1Diana Lizbeth Ortiz-Farias2Gerald Stanley Zavorsky3Clínica de Enfermedades Respiratorias, Hospital Regional de Alta Especialidad de La Peninsula de YucatanClínica de Enfermedades Respiratorias, Hospital Regional de Alta Especialidad de La Peninsula de YucatanClínica de Enfermedades Respiratorias, Hospital Regional de Alta Especialidad de La Peninsula de YucatanDepartment of Physiology and Membrane Biology, University of CaliforniaAbstract Background Few studies have assessed lung function in Hispanic subjects recovering from mild COVID-19. Therefore, we examined the prevalence of impaired pulmonary diffusing capacity for carbon monoxide (DLCO) as defined by values below the lower limit of normal (< LLN, < 5th percentile) or less than 80% of predicted in Hispanics recovering from mild COVID-19. We also examined the prevalence of a restrictive spirometric pattern as defined by the ratio of forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC) being ≥ LLN with the FVC being < LLN. Finally, we evaluated previous studies to find factors correlated to impaired DLCO post-COVID-19. Methods In this observational study, adult patients (n = 146) with mild COVID-19 were recruited from a long-term follow-up COVID-19 clinic in Yucatan, Mexico, between March and August 2021. Spirometry, DLCO, and self-reported signs/symptoms were recorded 34 ± 4 days after diagnosis. Results At post-evaluation, 20% and 30% of patients recovering from COVID-19 were classified as having a restrictive spirometric pattern and impaired DLCO, respectively; 13% had both. The most prevalent reported symptoms were fatigue (73%), a persistent cough (43%), shortness of breath (42%) and a blocked/runny nose (36%). Increased age and a restrictive spirometric pattern increased the probability of having an impaired DLCO while having a blocked nose and excessive sweating decreased the likelihood. The proportion of patients with previous mild COVID-19 and impaired DLCO increased by 13% when the definition of impaired DLCO was < 80% predicted instead of below the LLN. When comparing previous studies, having severe COVID-19 increased the proportion of those with impaired DLCO by 21% compared to those with mild COVID-19. Conclusions One-third of patients with mild COVID-19 have impaired DLCO thirty-four days post-diagnosis. The criteria that define impaired DLCO and the severity of COVID-19 disease affects the proportion of those with impaired DLCO at follow-up. One-fifth of patients have a restrictive spirometric pattern.https://doi.org/10.1186/s12890-022-02086-9Respiratory function testSARS-CoV-2MexicoDLCOLung
spellingShingle Arturo Cortes-Telles
Esperanza Figueroa-Hurtado
Diana Lizbeth Ortiz-Farias
Gerald Stanley Zavorsky
Clinical predictors of lung function in patients recovering from mild COVID-19
BMC Pulmonary Medicine
Respiratory function test
SARS-CoV-2
Mexico
DLCO
Lung
title Clinical predictors of lung function in patients recovering from mild COVID-19
title_full Clinical predictors of lung function in patients recovering from mild COVID-19
title_fullStr Clinical predictors of lung function in patients recovering from mild COVID-19
title_full_unstemmed Clinical predictors of lung function in patients recovering from mild COVID-19
title_short Clinical predictors of lung function in patients recovering from mild COVID-19
title_sort clinical predictors of lung function in patients recovering from mild covid 19
topic Respiratory function test
SARS-CoV-2
Mexico
DLCO
Lung
url https://doi.org/10.1186/s12890-022-02086-9
work_keys_str_mv AT arturocortestelles clinicalpredictorsoflungfunctioninpatientsrecoveringfrommildcovid19
AT esperanzafigueroahurtado clinicalpredictorsoflungfunctioninpatientsrecoveringfrommildcovid19
AT dianalizbethortizfarias clinicalpredictorsoflungfunctioninpatientsrecoveringfrommildcovid19
AT geraldstanleyzavorsky clinicalpredictorsoflungfunctioninpatientsrecoveringfrommildcovid19